A highly sensitive near-infrared fluorescent detection method to analyze signalling pathways by reverse-phase protein array

Proteomics

Volumn 9, Issue 24, 2009, Pages 5446-5454

  Dupuy, Laurence ^a,b,c,d   Gauthier, Christophe ^a,b,c,d   Durand, Guillaume ^a,b,c,d   Musnier, Astrid ^a,b,c,d   Heitzler, Domitille ^a,b,c,d   Herledan, Adrien ^e   Sakanyan, Vehary ^e,f   Crépieux, Pascale ^a,b,c,d   Reiter, Eric ^a,b,c,d  

^a UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE TOURS   (France)

^d Haras Nationaux   (France)

^e UNIVERSITÉ DE NANTES   (France)

^f ProtNeteomix   (France)

Author keywords

Cell signalling; FSH; Near infrared fluorescence; Reverse phase protein arrays

Indexed keywords

FOLLITROPIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEIN;

ARTICLE; CELL STRAIN HEK293; CORRELATION ANALYSIS; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN MICROARRAY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; FLUORESCENCE; FOLLICLE STIMULATING HORMONE; HUMANS; PHOSPHORYLATION; PROTEIN ARRAY ANALYSIS; PROTEINS; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SPECTROSCOPY, NEAR-INFRARED;

EID: 73149086622     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200900209     Document Type: Article

References (29)

1. Mann, M., Jensen, O. N., Proteomic analysis of post-translational modifications. Nat. Biotechnol. 2003, 21, 255-261.
2. Paweletz, C. P., Charboneau, L., Bichsel, V. E., Simone, N. L. et al., Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001, 20, 1981-1989.
3. Spurrier, B., Ramalingam, S., Nishizuka, S., Reverse-phase protein lysate microarrays for cell signaling analysis. Nat. Protoc. 2008, 3, 1796-1808.
4. Wulfkuhle, J. D., Aquino, J. A., Calvert, V. S., Fishman, D. A. et al., Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 2003, 3, 2085-2090.
5. Tibes, R., Qiu, Y., Lu, Y., Hennessy, B. et al., Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol. Cancer Ther. 2006, 5, 2512-2521.
6. Jiang, R., Mircean, C., Shmulevich, I., Cogdell, D. et al., Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays. Proteomics 2006, 6, 2964-2971.
7. Nishizuka, S., Charboneau, L., Young, L., Major, S. et al., Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc. Natl. Acad. Sci. USA 2003, 100, 14229-14234.
8. Chan, S. M., Ermann, J., Su, L., Fathman, C. G., Utz, P. J., Protein microarrays for multiplex analysis of signal transduction pathways. Nat. Med. 2004, 10, 1390-1396.
9. Winters, M. E., Mehta, A. I., Petricoin, E. F., 3rd, Kohn, E. C., Liotta, L. A., Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis. Cancer Res. 2005, 65, 3853-3860.
10. Loebke, C., Sueltmann, H., Schmidt, C., Henjes, F. et al., Infrared-based protein detection arrays for quantitative proteomics. Proteomics 2007, 7, 558-564.
11. Majidi, M., Al-Wadei, H. A., Takahashi, T., Schuller, H. M., Nongenomic beta estrogen receptors enhance beta1 adrenergic signaling induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human small airway epithelial cells. Cancer Res. 2007, 67, 6863-6871.
12. Espina, V., Woodhouse, E. C., Wulfkuhle, J., Asmussen, H. D. et al., Protein microarray detection strategies: focus on direct detection technologies. J. Immunol. Methods 2004, 290, 121-133.
13. Schutz-Geschwender, A., Zhang, Y., Holt, T., McDermitt, D., Olive, M., Quantitative, Two-Color Western blot detection with infrared fluorescence. Application Note. LI-COR Biosciences. 2004.
14. Chung, J. Y., Lee, S. J., Kris, Y., Braunschweig, T. et al., A well-based reverse-phase protein array applicable to extracts from formalin-fixed paraffin-embedded tissue. Proteomics Clin. Appl. 2008, 2, 1539-1547.
15. Pawlak, M., Schick, E., Bopp, M. A., Schneider, M. J. et al., Zeptosens' protein microarrays: a novel high performance microarray platform for low abundance protein analysis. Proteomics 2002, 2, 383-393.
16. Snapyan, M., Lecocq, M., Guevel, L., Arnaud, M. C. et al., Dissecting DNA-protein and protein-protein interactions involved in bacterial transcriptional regulation by a sensitive protein array method combining a near-infrared fluorescence detection. Proteomics 2003, 3, 647-657.
17. Sakanyan, V., Yeretssian, G., Near infrared fluorescence detection of antigen-antibody interactions on microarrays. in Sem, D, (Ed.), Spectral Techniques in Proteomics. CRC Press, Boca Raton, London, New York 2007, pp. 185-205.
18. Ghochikyan, A., Karaivanova, I. M., Lecocq, M., Vusio, P. et al., Arginine operator binding by heterologous and chimeric ArgR repressors from Escherichia coli and Bacillus stearothermophilus. J. Bacteriol. 2002, 184, 6602-6614.
19. Calvert, V. S., Tang, Y., Boveia, V., Wulfkuhle, J. et al., Development of multiplexed protein profiling and detection using near infrared detection of reverse-phase protein microarrays. Clin. Proteom. J. 2004, 1, 81-90.
20. Wulfkuhle, J. D., Speer, R., Pierobon, M., Laird, J. et al., Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. J. Proteome. Res. 2008, 7, 1508-1517.
21. Sheehan, K. M., Calvert, V. S., Kay, E. W., Lu, Y. et al., Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol. Cell. Proteomics 2005, 4, 346-355.
22. Rimm, D. L., What brown cannot do for you. Nat. Biotechnol. 2006, 24, 914-916.
23. Kara, E., Crepieux, P., Gauthier, C., Martinat, N. et al., A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation. Mol. Endocrinol. 2006, 20, 3014-3026.
24. Calvo, K. R., Dabir, B., Kovach, A., Devor, C. et al., IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. Blood 2008, 112, 3818-3826.
25. Liotta, L. A., Espina, V., Mehta, A. I., Calvert, V. et al., Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 2003, 3, 317-325.
26. Chung, J. Y., Braunschweig, T., Baibakov, G., Galperin, M. et al., Transfer and multiplex immunoblotting of a paraffin embedded tissue. Proteomics 2006, 6, 767-774.
27. Korf, U., Löbke, C., Haller, F., S. ultmann, H., Poutska, A., Infrared-based protein detection arrays for quantitative proteomics. Expert Opin. Drug Discov. 2008, 3, 273-283.
28. Luo, S., Wehr, N. B., Levine, R. L., Quantitation of protein on gels and blots by infrared fluorescence of Coomassie blue and Fast Green. Anal. Biochem. 2006, 350, 233-238.
29. Ekins, R. P., Chu, F. W., Multianalyte microspot immunoassay- microanalytical "compact disk" of the future. Clin. Chem. 1991, 37, 1955-1967.